New Tel Aviv University study attempts to put to rest an ongoing debate over when, and from which direction, the elusive, artistic Aurignacian culture was brought to the Levan.
Measuring children’s gaze patterns as they watch movies of social interactions is a reliable way to accurately identify nearly half of autism spectrum disorder (ASD) cases, according to a new study just published in Autism Research by BGU researchers.
The Ben-Gurion University of the Negev was able to use a new biotechnology to cultivate a single-sex population of prawns (Macrobrachium rosenbergii) that will act as a biological agent.
Sonovia’s technique, developed at Bar-Ilan University, could also make fabrics fire resistant, water repellant and even body odor-proof. Chemistry professors Aharon Gedanken and Ilana Perelshtein from Bar-Ilan University have developed a new way to bacteria-proof the fabrics used in a hospital.
A new study by BGU researchers as part of the global Immunological Genome Project (ImmGen) has tackled this question by comparing the transcriptome of the immune system of female and male mice.
Technion’s computerized pathologist decodes cancer signatures to improve personalized medicine. Researchers at the Technion-Israel Institute of Technology have now used artificial intelligence and big data to decode the unique signatures of certain cancer cells.
Science can offer Olympic athletes the tools necessary to increase their performances by those marginal but crucial percentages.
In two cases, a single dose of VMT induced a long-lasting and complete remission.
The discovery is the earliest evidence of delayed consumption. Researchers from Tel Aviv University and Spain have discovered the earliest known evidence of the storage and delayed consumption of animal bone marrow – some 400,000 years ago by prehistoric humans near Tel Aviv.
In a new study of adolescent and adult athletes, researchers at BGU, Stanford University and Trinity College in Dublin have found evidence of damage to the brain’s protective barrier, without a reported concussion.
Glioblastoma, a typically incurable brain cancer, is a master of diversity. Not only do the tumors differ from one patient to the next, but cells within each tumor differ greatly from one another.
Hundreds of millions of years have passed since we split off from our common ancestor with bacteria, but we still share a kind of immune system with them.
BGN Technologies, BGU’s technology transfer company, has entered into an exclusive worldwide license agreement with Vaxil Bio (TSX VENTURE: VXL), a biotech company focusing on innovative immunotherapy treatments for cancer and infectious diseases, for the development and commercialization of targeted cancer therapy.